AUM Biosciences attended the “US-China Biopharma Innovation & Investment Summit” in Shanghai on October 22 – 23, 2018

AUM Biosciences  attended the 2-day US-China Biopharma Innovation & Investment Summit that was held at the Shanghai Four Seasons, in Shanghai.

China’s biotech scene has been exploding over the past 2 years, presenting start-ups, especially those from Asia, with huge opportunities. The conference brings together movers and shakers in the emerging healthcare markets with a forecast on drug innovation and a special focus on the regulatory scene.

More information about the event can be found here.

For any additional queries, please contact